John P. Huberty

Phase II Study on the Effect of Disease Sites, Age, and Prior Therapy on Response to Iodine-131-Metaiodobenzylguanidine Therapy in Refractory Neuroblastoma

Katherine K. Matthay, Gregory A. Yanik, Julia A. Messina et al. · Journal of Clinical Oncology · 2007 · 265 citations

Medicine, Nuclear Medicine, Oncology +12

Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies.

Alberto Gabizón, Danny C. Price, John P. Huberty et al. · PubMed · 1990 · 250 citations

Pharmacy, Oncology, Pharmacology +16

Phase II Study of High-Dose [¹³¹I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma

Sara L. Gonias, Robert E. Goldsby, Katherine K. Matthay et al. · Journal of Clinical Oncology · 2009 · 241 citations · Full text

Medicine, Oncology, Pharmacology +11

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma.

Katherine K. Matthay, Kenneth B. DeSantes, B.H. Hasegawa et al. · Journal of Clinical Oncology · 1998 · 221 citations

Medicine, Oncology, Pharmacology +15

Scintigraphic assessment of regional cardiac adrenergic innervation.

Michael W. Dae, J. William O’Connell, Elias H. Botvinick et al. · Circulation · 1989 · 195 citations · Full text

Medicine, Cardiology, Nuclear Medicine +17